FdaApplication
ANDA 205643
Identifiers
- fda_app_no: ANDA205643
Properties
| Property | Value |
|---|---|
| applicant_name | EXELA PHARMA SCIENCES LLC |
| application_type | ANDA |
| approval_date | 2023-11-01 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ACETYLCYSTEINE | ACETYLCYSTEINE | 20% | SOLUTION;INHALATION, ORAL |
1 product